查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1618829

儿科医疗保健市场：按治疗、适应症和最终用户划分 - 全球预测 2025-2030

Paediatric Healthcare Market by Treatment (Immunotherapy, Medications, Surgeries), Indication (Asthma & Allergies, Cardiac Disorders, Genetic Disorders), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年儿科医疗保健市场价值为1,070.1亿美元，预计到2024年将达到1,145.5亿美元，复合年增长率为7.53%，到2030年将达到1,779.4亿美元。

儿科医疗保健市场涵盖各种针对从新生儿到青少年的儿童独特医疗需求的服务。这个领域至关重要，因为它解决了与成人截然不同的特定发展、营养和社会心理需求。儿科医疗保健不仅限于治疗，还包括预防保健、诊断和治疗性介入，最终用途包括医院、诊所和专科医疗中心。主要成长要素包括医疗设备和药品的技术进步、儿童健康意识的提高以及儿童疾病的增加。由于便利性和可近性的提高，对远端医疗的需求激增，为相关人员提供了有利可图的机会。此外，小儿科对慢性疾病的深入研究为技术创新提供了巨大的潜力。然而，严格的法律规范、先进医疗保健解决方案的高成本以及获得优质医疗设施的差异等挑战正在阻碍市场成长。该行业必须应对这些挑战，特别是倡导全面和支持性的医疗保健政策。创新应着重于开发具有成本效益的医疗设备，并为服务不足的人增强远端医疗解决方案。此外，将人工智慧 (AI) 纳入诊断和患者管理系统可以增强个人化护理。为了实现业务成长，明智的做法是投资儿科疫苗开发，特别是针对快速成长的病毒威胁，并探索与高科技公司合作开发智慧健康解决方案。此外，开发适合儿科的可穿戴健康技术以持续监测健康指标并促进预防性健康管理具有巨大潜力。从本质上讲，儿科医疗保健市场竞争激烈，但前景广阔，其特点是不断的研究和改善全球儿童健康的强大动力。为了利用这些动态，公司必须优先考虑创新和策略联盟，同时了解技术趋势和监管变化。

主要市场统计
基准年[2023] 1070.1亿美元
预计年份 [2024] 1145.5亿美元
预测年份 [2030] 1779.4亿美元
复合年增长率（%） 7.53%

市场动态：揭示快速发展的儿科医疗保健市场的关键市场洞察

供需的动态交互作用正在改变儿科医疗保健市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 病毒感染和营养不良导致的死亡人数增加
    • 增加政府支持和倡议以促进儿童健康
    • 提高家长对适当治疗的认识
  • 市场限制因素
    • 伦理问题和研究参与者人数较少
  • 市场机会
    • 技术进步中研发不断上升
    • 新兴国家医疗费用快速上涨
  • 市场挑战
    • 全球小儿科短缺

波特五力：驾驭儿科医疗市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解儿科医疗保健市场的外部影响

外部宏观环境因素在塑造儿科医疗市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解儿科医疗市场的竞争格局

对儿科医疗保健市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 儿科医疗保健市场定位矩阵供应商绩效评估

FPNV定位矩阵是评估儿科医疗保健市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製儿科医疗保健市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，儿科医疗保健市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 病毒感染和营养不良导致的死亡人数增加
      • 加大政府支持并努力促进儿童健康
      • 家长寻求适当治疗的意识不断增强
    • 抑制因素
      • 伦理问题和研究对象数量较少
    • 机会
      • 扩大技术进步的研究和开发
      • 新兴国家医疗费用快速上涨
    • 任务
      • 全球小儿科短缺
  • 市场区隔分析
    • 治疗：扩大儿科医疗保健的覆盖范围，以针对各种健康状况进行免疫治疗
    • 适应症：儿科医疗保健领域对有效、适合年龄的药物来控制气喘和过敏的需求不断增长。
    • 最终用户：在提供广泛服务的医院和诊所中越来越多地使用儿科医疗保健
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 依治疗分类的儿科医疗市场

  • 免疫疗法
  • 药品
  • 外科手术

第七章儿科医疗市场（按适应症）

  • 气喘和过敏
  • 心臟病
  • 遗传疾病
  • 代谢紊乱

第八章儿科医疗保健市场：依最终用户分类

  • 门诊治疗中心
  • 家庭护理设置
  • 医院/诊所

第九章美洲儿科医疗保健市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区儿科医疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲儿科医疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Cortica 在新资金筹措中筹集 7,500 万美元并收购 Springtide Child Development
    • 儿科行为健康提供者 Bend Health 获得 3,200 万美元资金筹措
    • Ipsen 收购 Albireo 以加速小儿肝病治疗罕见疾病领域的成长
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • AstraZeneca PLC
  • Aveanna Healthcare, LLC.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Boehringer Ingelheim International GmbH
  • Eisai Co., Ltd.
  • Eli Lilly and Company
  • Enviva Inc.
  • Gilead Sciences, Inc.
  • Glaxosmithkline PLC
  • GP Pharm, SA
  • Henin Lukinz Pvt. Ltd.
  • Interim HealthCare Inc.
  • Janssen Global Services LLC
  • Johnson & Johnson Services, Inc.
  • Medexus Pharmaceuticals, Inc.
  • Medtronic PLC
  • Merck KGaA
  • Novartis AG
  • Olympus Corporation
  • ORPHELIA Pharma
  • Pfizer Inc.
  • Proveca Ltd.
  • Royal Philips
  • Sanofi SA
  • Siemens AG
  • Strykar Corporation
  • The Procter & Gamble Company
  • Thermo Fisher Scientific, Inc.
  • Viatris Inc.
Product Code: MRR-434CCDA04E27

The Paediatric Healthcare Market was valued at USD 107.01 billion in 2023, expected to reach USD 114.55 billion in 2024, and is projected to grow at a CAGR of 7.53%, to USD 177.94 billion by 2030.

The pediatric healthcare market encompasses various services tailored to the unique medical needs of children, from newborns to adolescents. This sector is essential because it addresses specific developmental, nutritional, and psychosocial requirements that are vastly different from adults. Pediatric healthcare extends beyond treatment to preventive care, diagnostics, and therapeutic interventions, with end-use involving hospitals, clinics, and specialty care centers. Key growth influencers include technological advancements in medical devices and pharmaceuticals, rising awareness of child health, and increasing incidences of pediatric diseases. The surge in demand for telemedicine, owing to convenience and enhanced accessibility, presents a lucrative opportunity for stakeholders. Additionally, the thriving focus on pediatric research for chronic illnesses offers significant potential for innovation. However, challenges like stringent regulatory frameworks, high costs of advanced healthcare solutions, and disparities in access to quality healthcare facilities pose obstacles to market growth. The industry must address these challenges, notably by advocating for more inclusive and supportive healthcare policies. Innovation should focus on developing cost-effective medical devices and enhancing telehealth solutions to reach underserved populations. Furthermore, the integration of artificial intelligence (AI) in diagnostics and patient management systems can enhance personalized care. For business growth, investing in pediatric vaccine development, especially for emergent viral threats, and exploring partnerships with tech companies for smart-health solutions can be prudent. Additionally, there is considerable potential in developing wearable health technology adapted for children to monitor health metrics continuously, thus fostering proactive health management. In nature, the pediatric healthcare market is competitive yet promising, characterized by ongoing research and a strong drive towards better health outcomes for children globally. To harness these dynamics, companies should remain updated on technological trends and regulatory changes while prioritizing innovation and strategic collaborations.

KEY MARKET STATISTICS
Base Year [2023] USD 107.01 billion
Estimated Year [2024] USD 114.55 billion
Forecast Year [2030] USD 177.94 billion
CAGR (%) 7.53%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Paediatric Healthcare Market

The Paediatric Healthcare Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing number of deaths attributed to viral infections and malnutrition
    • Rising government support and initiatives to promote pediatric health
    • Growing awareness among child parents for adequate treatment
  • Market Restraints
    • Ethical concerns and small size of the study population
  • Market Opportunities
    • Growing research and development in technological advancements
    • Surge in medical expenditure in emerging economies
  • Market Challenges
    • Lack of pediatricians across the globe

Porter's Five Forces: A Strategic Tool for Navigating the Paediatric Healthcare Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Paediatric Healthcare Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Paediatric Healthcare Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Paediatric Healthcare Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Paediatric Healthcare Market

A detailed market share analysis in the Paediatric Healthcare Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Paediatric Healthcare Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Paediatric Healthcare Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Paediatric Healthcare Market

A strategic analysis of the Paediatric Healthcare Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Paediatric Healthcare Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AstraZeneca PLC, Aveanna Healthcare, LLC., Becton, Dickinson and Company, bioMerieux SA, Boehringer Ingelheim International GmbH, Eisai Co., Ltd., Eli Lilly and Company, Enviva Inc., Gilead Sciences, Inc., Glaxosmithkline PLC, GP Pharm, S.A., Henin Lukinz Pvt. Ltd., Interim HealthCare Inc., Janssen Global Services LLC, Johnson & Johnson Services, Inc., Medexus Pharmaceuticals, Inc., Medtronic PLC, Merck KGaA, Novartis AG, Olympus Corporation, ORPHELIA Pharma, Pfizer Inc., Proveca Ltd., Royal Philips, Sanofi S.A, Siemens AG, Strykar Corporation, The Procter & Gamble Company, Thermo Fisher Scientific, Inc., and Viatris Inc..

Market Segmentation & Coverage

This research report categorizes the Paediatric Healthcare Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Treatment, market is studied across Immunotherapy, Medications, and Surgeries.
  • Based on Indication, market is studied across Asthma & Allergies, Cardiac Disorders, Genetic Disorders, and Metabolic Disorders.
  • Based on End-User, market is studied across Ambulatory Care Centers, Homecare Settings, and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing number of deaths attributed to viral infections and malnutrition
      • 5.1.1.2. Rising government support and initiatives to promote pediatric health
      • 5.1.1.3. Growing awareness among child parents for adequate treatment
    • 5.1.2. Restraints
      • 5.1.2.1. Ethical concerns and small size of the study population
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing research and development in technological advancements
      • 5.1.3.2. Surge in medical expenditure in emerging economies
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of pediatricians across the globe
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Treatment: Expanding usage of pediatric healthcare for immunotherapy for a myriad of health conditions
    • 5.2.2. Indication: Growing need for effective, age-appropriate medications in pediatric healthcare to manage asthma & allergies
    • 5.2.3. End-User: Growing usage of pediatric healthcare across hospitals & clinics that offer a wide range of services
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Paediatric Healthcare Market, by Treatment

  • 6.1. Introduction
  • 6.2. Immunotherapy
  • 6.3. Medications
  • 6.4. Surgeries

7. Paediatric Healthcare Market, by Indication

  • 7.1. Introduction
  • 7.2. Asthma & Allergies
  • 7.3. Cardiac Disorders
  • 7.4. Genetic Disorders
  • 7.5. Metabolic Disorders

8. Paediatric Healthcare Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Care Centers
  • 8.3. Homecare Settings
  • 8.4. Hospitals & Clinics

9. Americas Paediatric Healthcare Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Paediatric Healthcare Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Paediatric Healthcare Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Cortica Closes USD 75 Million in New Funding Round and Acquires Springtide Child Development
    • 12.3.2. Pediatric Behavioral Health Provider Bend Health Moves Out of Stealth Mode with USD 32M in Funding
    • 12.3.3. Ipsen to Acquire Albireo Accelerating Growth in Rare Disease with Treatments for Several Pediatric Liver Diseases
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. AstraZeneca PLC
  • 3. Aveanna Healthcare, LLC.
  • 4. Becton, Dickinson and Company
  • 5. bioMerieux SA
  • 6. Boehringer Ingelheim International GmbH
  • 7. Eisai Co., Ltd.
  • 8. Eli Lilly and Company
  • 9. Enviva Inc.
  • 10. Gilead Sciences, Inc.
  • 11. Glaxosmithkline PLC
  • 12. GP Pharm, S.A.
  • 13. Henin Lukinz Pvt. Ltd.
  • 14. Interim HealthCare Inc.
  • 15. Janssen Global Services LLC
  • 16. Johnson & Johnson Services, Inc.
  • 17. Medexus Pharmaceuticals, Inc.
  • 18. Medtronic PLC
  • 19. Merck KGaA
  • 20. Novartis AG
  • 21. Olympus Corporation
  • 22. ORPHELIA Pharma
  • 23. Pfizer Inc.
  • 24. Proveca Ltd.
  • 25. Royal Philips
  • 26. Sanofi S.A
  • 27. Siemens AG
  • 28. Strykar Corporation
  • 29. The Procter & Gamble Company
  • 30. Thermo Fisher Scientific, Inc.
  • 31. Viatris Inc.

LIST OF FIGURES

  • FIGURE 1. PAEDIATRIC HEALTHCARE MARKET RESEARCH PROCESS
  • FIGURE 2. PAEDIATRIC HEALTHCARE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. PAEDIATRIC HEALTHCARE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. PAEDIATRIC HEALTHCARE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PAEDIATRIC HEALTHCARE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PAEDIATRIC HEALTHCARE MARKET DYNAMICS
  • TABLE 7. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY SURGERIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY ASTHMA & ALLERGIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY CARDIAC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. PAEDIATRIC HEALTHCARE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 148. PAEDIATRIC HEALTHCARE MARKET, FPNV POSITIONING MATRIX, 2023